Alpha DNA Investment Management’s Lowe's Companies LOW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,079
Closed -$1.23M 148
2022
Q1
$1.23M Buy
+6,079
New +$1.4M 0.86% 53
2021
Q3
Sell
-9,470
Closed -$1.84M 132
2021
Q2
$1.84M Buy
9,470
+9,327
+6,522% +$1.82M 1.25% 8
2021
Q1
$26K Sell
143
-6,147
-98% -$1.05M 0.03% 231
2020
Q4
$1.01M Buy
+6,290
New +$1.02M 1.08% 16

Other funds holding LOW

Alpha DNA Investment Management's LOW Position: Q2 2022 in Review

Alpha DNA Investment Management sold out of Lowe's Companies (LOW) in Q2 2022, closing a stake of 6,079 shares — an estimated $1.23M sold.

Alpha DNA Investment Management first reported a position in LOW in Q4 2020 and held it in 4 quarters. The position peaked at $1.84M in Q2 2021. 2,167 funds tracked by Wall St. Rank hold LOW as of Q2 2022.

  • Alpha DNA Investment Management reported no remaining Lowe's Companies position as of Q2 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 6,079 Lowe's Companies shares in Q2 2022, an estimated $1.23M.
  • Alpha DNA Investment Management first reported a position in Lowe's Companies in Q4 2020 and held it in 4 quarters.
  • Alpha DNA Investment Management's Lowe's Companies position peaked at $1.84M in Q2 2021.
  • 2,167 funds tracked by Wall St. Rank held Lowe's Companies as of Q2 2022.

Based on Alpha DNA Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.